Nasrat should take a deal if available to get us much needed funding for trials. Even if it's not the ideal agreement in terms of royalty percentage or whatever, it still allows us to get our next 1-3 ADT products to market ultimately, while also giving us a break on cash burn and giving more time for the FDA to approve the new generics. Also having a big name associated with us gives us instant credibility, IMO.